Takeda Pharmaceutical Co., Ltd. et al v. Mylan Inc. et al

Filing 53

ORDER GRANTING MOTION TO RELATE AND CONSOLIDATE CASESby Judge Lucy H. Koh granting (52) Motion to Relate Case in case 5:13-cv-04001-LHK; granting (48) Motion to Relate Case in case 5:13-cv-04002-LHK. Case 14-cv-00314 is related to this case. (mpb, COURT STAFF) (Filed on 2/7/2014)

1

(All parties and counsel listed on Signature Page)

2
3
4
5
6
7
8

UNITED STATES DISTRICT COURT
FOR THE NORTHERN DISTRICT OF CALIFORNIA
SAN JOSE DIVISION

9
10
11

TAKEDA PHARMACEUTICAL CO., LTD.,
TAKEDA PHARMACEUTICALS U.S.A.,
INC., AND TAKEDA
PHARMACEUTICALS AMERICA, INC.,

12

Case No. 5:13-cv-4001 LHK (PSG)
STIPULATION AND [PROPOSED]
ORDER TO RELATE AND
CONSOLIDATE CASES

Plaintiffs,
13
vs.
14
15

MYLAN INC. AND
MYLAN PHARMACEUTICALS INC.,

Judge: Hon. Lucy H. Koh
Magistrate Judge: Hon. Paul S. Grewal

16
17
18
19

Defendants.
TAKEDA PHARMACEUTICAL CO., LTD.,
TAKEDA PHARMACEUTICALS U.S.A.,
INC., AND TAKEDA
PHARMACEUTICALS AMERICA, INC.,
Plaintiffs,

20
21
22
23

Case No. 5:13-cv-4002 LHK (PSG)

vs.
MYLAN INC. AND
MYLAN PHARMACEUTICALS INC.,
Defendants.

24
25
26
27
28
Case Nos. 5:13-cv-4001, -4002, 3:14-cv-314
STIPULATION AND [PROPOSED] ORDER TO RELATE AND CONSOLIDATE CASES

1
2

TAKEDA PHARMACEUTICAL CO., LTD.,
TAKEDA PHARMACEUTICALS U.S.A.,
INC., AND TAKEDA
PHARMACEUTICALS AMERICA, INC.,

Case No. 3:14-cv-314 EMC

3
Plaintiffs,
4
v.
5
6
7

MYLAN INC. AND
MYLAN PHARMACEUTICALS INC.,
Defendants.

8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
Case Nos. 5:13-cv-4001, -4002, 3:14-cv-314
STIPULATION AND [PROPOSED] ORDER TO RELATE AND CONSOLIDATE CASES

1

Plaintiffs Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals U.S.A, Inc.,

2

and Takeda Pharmaceuticals America, Inc. (collectively, “Takeda”), and Defendants Mylan Inc.

3

and Mylan Pharmaceuticals Inc. (collectively, “Mylan”), hereby stipulate through their respective

4

attorneys as follows:

5

WHEREAS, the above-captioned actions, Takeda Pharmaceutical Co., Ltd. et al. v.

6

Mylan Inc. and Mylan Pharmaceuticals Inc., No. 5:13-cv-4001 LHK (PSG) (N.D. Cal.) (the

7

“4001 Action”); Takeda Pharmaceutical Co., Ltd. et al. v. Mylan Inc. and Mylan

8

Pharmaceuticals Inc., No. 5:13-cv-4002 LHK (PSG) (N.D. Cal.) (the “4002 Action”); and

9

Takeda Pharmaceutical Co., Ltd. et al. v. Mylan Inc. and Mylan Pharmaceuticals Inc., No. 3:14-

10

cv-314 EMC (N.D. Cal.) (the “314 Action”), between Takeda and Mylan are pending in this

11

District;

12

WHEREAS, the Court related the 4001 and 4002 Actions to each other pursuant to Civil

13

Local Rule 3-12 on October 23, 2013, Order Relating Cases Pursuant to Civil Local Rule 3-12

14

[No. 5:13-cv-4001 D.N.30; No. 5:13-cv-4002 D.N. 25];

15

WHEREAS, during the Case Management Conference held in the 4001 and 4002 Actions

16

on February 5, 2014, the Court suggested that, in the interest of efficiency and conservation of

17

resources, the 314 Action should also be related to the 4001 and 4002 Actions;

18
19
20
21
22
23
24

IT IS HEREBY STIPULATED AND AGREED, subject to the approval of the Court, as
follows.
1.

The 314 Action should be designated as related to the 4001 and 4002 Actions

pursuant to Local Civil Rule 3-12.
2.

The 4001, 4002, and 314 Actions shall be consolidated for all purposes, including

trial, pursuant to Rule 42(a) of the Federal Rules of Civil Procedure.
3.

The schedule set by the Court in the 4001 and 4002 Actions during the Case

25

Management Conference held on February 5, 2014 as well as any related case management order

26

entered by the Court shall apply to the 314 Action.

27
28

4.

Solely for the purpose of the 314 Action, Counsel of Record for Mylan in the 4001

and 4002 Actions will accept service by electronic mail of the summons and complaint in the 314
Case Nos. 5:13-cv-4001, -4002, 3:14-cv-314
-1STIPULATION AND [PROPOSED] ORDER TO RELATE AND CONSOLIDATE CASES

1

Action on behalf of Mylan. Notwithstanding the foregoing, as of the date of this stipulation,

2

service has not been made in the 314 Action. The timing for Mylan to answer or otherwise move

3

against the complaint in the 314 Action will be determined by the date upon which service is

4

perfected.

5
6
7

DATED: February 7, 2014

TAKEDA PHARMACEUTICAL CO., LTD.,
TAKEDA PHARMACEUTICALS U.S.A., INC.,
AND TAKEDA PHARMACEUTICALS
AMERICA, INC.

8
9
10
11
12
13
14
15
16
17
18
19
20
21

By:
/s/ Heather E. Takahashi
Jeffrey I. Weinberger (SBN 056214)
[e-mail]
Ted G. Dane (SBN 143195)
[e-mail]
Heather E. Takahashi (SBN 245845)
[e-mail]
Ryan N. Hagglund (pro hac vice)
[e-mail]
MUNGER, TOLLES & OLSON LLP
355 South Grand Ave., 35th Floor
Los Angeles, CA 90071-1560
Telephone: [phone]
Facsimile: [phone]
Eric K. Chiu (SBN 244144)
[e-mail]
Tina W. Arroyo (SBN 272757)
[e-mail]
MUNGER, TOLLES & OLSON LLP
560 Mission Street
San Francisco, California 94105-2907
Telephone:
[phone]
[phone]
Facsimile:

22
23
24
25
26
27
28
Case Nos. 5:13-cv-4001, -4002, 3:14-cv-314
-2STIPULATION AND [PROPOSED] ORDER TO RELATE AND CONSOLIDATE CASES

1

MYLAN INC. AND
MYLAN PHARMACEUTICALS INC.

2
3
4
5
6
7

By:
/s/ Ryan W. Koppelman
Ryan W. Koppelman (SBN 290704)
[e-mail]
ALSTON & BIRD LLP
275 Middlefield Road, Suite 150
Menlo Park, California 94025-4008
[phone] (telephone)
[phone] (facsimile)

8
9
10
11
12
13
14
15
16
17
18
19

Deepro R. Mukerjee (pro hac vice)
[e-mail]
Alexander S. Lorenzo (pro hac vice)
[e-mail]
Poopak Banky (pro hac vice)
[e-mail]
ALSTON & BIRD LLP
90 Park Avenue
New York, New York 10016-1387
[phone] (telephone)
[phone] (facsimile)
Bryan Skelton (pro hac vice forthcoming)
[e-mail]
ALSTON & BIRD LLP
4721 Emperor Boulevard, Suite 400
Raleigh, North Carolina 27703-8580
[phone] (telephone)
[phone] (facsimile)

20
21
22
23
24
25
26
27
28
Case Nos. 5:13-cv-4001, -4002, 3:14-cv-314
-3STIPULATION AND [PROPOSED] ORDER TO RELATE AND CONSOLIDATE CASES

1
2
3

PURSUANT TO STIPULATION, IT IS SO ORDERED.
7, 2014
DATED: February __, 2014

4
THE HONORABLE LUCY H. KOH
UNITED STATES DISTRICT JUDGE

5
6
7
8
9
10

Filer’s Attestation

11

I, Heather E. Takahashi, am the ECF user whose identification and password are being
12
used to file this STIPULATION AND [PROPOSED] ORDER TO RELATE AND
13
CONSOLIDATE CASES. In compliance with General Order 45.X.B., I hereby attest that the
14
above-named signatories concur in this filing.
15
16
17

DATED: February 7, 2014
/s/ Heather E. Takahashi
Heather E. Takahashi

18
19
20
21
22
23
24
25
26
27
28
Case Nos. 5:13-cv-4001, -4002, 3:14-cv-314
-4STIPULATION AND [PROPOSED] ORDER TO RELATE AND CONSOLIDATE CASES